• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Omega Therapeutics Inc (NQ: OMGA )

    1.930 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 1.930
    Bid (Size) 1.870 (8)
    Ask (Size) 1.920 (3)
    Prev. Close 1.930
    Today's Range 1.930 - 1.930
    52wk Range 1.300 - 6.300
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
    Former Merck veteran brings extensive expertise across corporate finance, business development and corporate licensing 
    From Omega Therapeutics
    Via GlobeNewswire
    Expert Ratings For Omega Therapeutics
    Via Benzinga

    Performance

    YTD
    -35.02%
    -35.02%
    1 Month
    -9.81%
    -9.81%
    3 Month
    -34.80%
    -34.80%
    6 Month
    -55.63%
    -55.63%
    1 Year
    -62.38%
    -62.38%

    More News

    Read More
    Omega Therapeutics To Participate In Two Upcoming Investor Conferences
    From Omega Therapeutics
    Via GlobeNewswire
    Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
    From Omega Therapeutics
    Via GlobeNewswire
    4 Analysts Have This To Say About Omega Therapeutics
    Via Benzinga
    How Is The Market Feeling About Omega Therapeutics?
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
    From Omega Therapeutics
    Via GlobeNewswire
    OMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
    From Omega Therapeutics
    Via GlobeNewswire
    Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
    From Omega Therapeutics
    Via GlobeNewswire
    Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
    From Omega Therapeutics
    Via GlobeNewswire
    OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
    From Omega Therapeutics
    Via GlobeNewswire
    Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
    From Omega Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    The 3 Best Biotech Stocks to Buy in January 2024
    Via InvestorPlace
    Nvidia, Spotify Lead Five Stocks Near Buy Points
    Via Investor's Business Daily
    Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review
    Via Investor's Business Daily
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    Via Benzinga
    Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
    Via Investor's Business Daily
    Why Novo Nordisk Stock Crushed the Market Today
    Via The Motley Fool
    Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.